Clinical, hemodynamic, and neuroendocrine effects of chronic prazosin therapy for congestive heart failure
- 1 September 1981
- journal article
- review article
- Published by Elsevier in American Heart Journal
- Vol. 102 (3) , 615-621
- https://doi.org/10.1016/0002-8703(81)90753-5
Abstract
No abstract availableKeywords
This publication has 17 references indexed in Scilit:
- Long-term therapy of heart failure with prazosin: A randomized double blind trialPublished by Elsevier ,1980
- Comparison of haemodynamic effects of oral prazosin, oral hydralazine, and intravenous nitroprusside in same patients with chronic heart failure.Heart, 1979
- Marked early attenuation of hemodynamic effects of oral prazosin therapy in chronic congestive heart failureThe American Journal of Cardiology, 1979
- Attenuation of Prazosin Effect on Cardiac Output in Chronic Heart FailureAnnals of Internal Medicine, 1979
- Paradox of improved exercise but not resting hemodynamics with short-term prazosin in chronic heart failureThe American Journal of Cardiology, 1979
- Hemodynamic and clinical tachyphylaxis to prazosin-mediated afterload reduction in severe chronic congestive heart failure.Circulation, 1979
- Effect of prazosin vs placebo on chronic left ventricular heart failure.Circulation, 1979
- Efficacy of ambulatory systemic vasodilator therapy with oral prazosin in chronic refractory heart failure. Concomitant relief of pulmonary congestion and elevation of pump output demonstrated by improvements in symptomatology, exercise tolerance, hemodynamics and echocardiography.Circulation, 1977
- Sustained Reduction of Cardiac Impedance and Preload in Congestive Heart Failure with the Antihypertensive Vasodilator PrazosinNew England Journal of Medicine, 1977
- PHENTOLAMINE FOR VASODILATOR TREATMENT OF SEVERE HEART-FAILUREThe Lancet, 1971